{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:57:10Z","timestamp":1761929830402},"reference-count":7,"publisher":"Medwave Estudios Limitada","issue":"Suppl2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medwave"],"DOI":"10.5867\/medwave.2016.6469","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T16:57:02Z","timestamp":1466182622000},"page":"e6469-e6469","source":"Crossref","is-referenced-by-count":1,"title":["Is pentoxifylline effective in alcoholic hepatitis? \u2013First update"],"prefix":"10.5867","volume":"16","author":[{"given":"Gabriel","family":"Rada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mat\u00edas","family":"Arteaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Candia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3888","published-online":{"date-parts":[[2016,6,14]]},"reference":[{"issue":"9","key":"ref0","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/apt.12279","article-title":"Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis.","volume":"37","author":"Parker","year":"2013","unstructured":"Parker R, Armstrong MJ, Corbett C, Rowe IA, Houlihan DD. Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis. Aliment Pharmacol Ther. 2013 May;37(9):845-54. | CrossRef | PubMed |","journal-title":"Aliment Pharmacol Ther","ISSN":"http:\/\/id.crossref.org\/issn\/0269-2813","issn-type":"print"},{"issue":"4","key":"ref1","doi-asserted-by":"publisher","first-page":"CD007339","DOI":"10.1002\/14651858.cd007339.pub2","article-title":"Pentoxifylline for alcoholic hepatitis.","author":"Whitfield","year":"2009","unstructured":"Whitfield K, Rambaldi A, Wetterslev J, Gluud C. Pentoxifylline for alcoholic hepatitis. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007339. | CrossRef | PubMed |","journal-title":"Cochrane Database Syst Rev","ISSN":"http:\/\/id.crossref.org\/issn\/1469-493X","issn-type":"print"},{"issue":"5","key":"ref2","first-page":"1635","article-title":"Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis. Gastroenterology. 2010 May;138(5):1755-62. | CrossRef | PubMed | Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000 Dec;119(6):1637-48. | PubMed | Karnam US. A toast to pentoxifylline.","volume":"96","author":"Singh","year":"2001","unstructured":"Singh S, Murad MH, Chandar AK, Bongiorno CM, Singal AK, Atkinson SR, et al. Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis. Gastroenterology. 2015 Oct;149(4):958-70.e12. | CrossRef | PubMed | Lebrec D, Thabut D, Oberti F, Perarnau JM, Condat B, Barraud H, et al. Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis. Gastroenterology. 2010 May;138(5):1755-62. | CrossRef | PubMed | Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000 Dec;119(6):1637-48. | PubMed | Karnam US. A toast to pentoxifylline. Am J Gastroenterol. 2001 May;96(5):1635-7. | PubMed |","journal-title":"Am J Gastroenterol","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Sidhu SS, Goyal O, Singla P, Gupta D, Sood A, Chhina RS, et al. Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial). Dig Dis Sci. 2012 Jun;57(6):1664-71. | CrossRef | PubMed | Mathurin P, Louvet A, Dao T, Nahon P, Diaz E, Carbonell E, et al. Addition of pentoxifylline to prednisolone for severe alcoholic hepatitis does not improve 6-month survival: Results of the CORPENTOX trial. Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting (62nd : California); 20112011. | Link |","DOI":"10.1007\/s10620-012-2097-4"},{"key":"ref4","first-page":"249A","article-title":"Pentoxifylline reduces disease severity and prevents renal impairment in severe acute alcoholic hepatitis: A double blind, placebo controlled trial.","volume-title":"58th Annual Meeting of the American Association for the Study of Liver Diseases","author":"Sidhu","year":"1997","unstructured":"Sidhu S, Singla M, Bhatia KL. Pentoxifylline reduces disease severity and prevents renal impairment in severe acute alcoholic hepatitis: A double blind, placebo controlled trial. Hepatology. 2006 2006;44(4 Suppl 1):373A-4A. | Link | Paladugu H, Sawant P, Dalvi L, Kudalkar J. Role of pentoxifylline in treatment of severe acute alcoholic hepatitis \u2013 a randomized controlled trial. Journal of Gastroenterology and Hepatology. 2006 2006;21(supp s6):A459. | CrossRef | McHutchison, JG, Runyon, BA, Draguesku, JO, Comineelli, F, Person, JL, J, Castracane. Pentoxifylline may prevent renal impairment (hepatorenal syndrome) in severe acute alcoholic hepatitis. Hepatology. 1991;14(4 (Pt 2)):96. Lebrec D, Thabut D, Oberti F, Perarnau JM, Condat B, Barraud H, et al. Pentoxifylline for the treatment of patients with advanced cirrhosis. A randomized, placebo-controlled, double-blind trial. 58th Annual Meeting of the American Association for the Study of Liver Diseases; 20072007. p. 249A. | Link | Akriviadis, E, Botla, R, Briggs, W, Han, S, Reynolds, T, Shakil, O. Improved short-term survival with pentoxifylline treatment in severe acute alcoholic hepatitis. Hepatology. 1997;26(4):250A"},{"key":"ref5","first-page":"20","article-title":"Pentoxifylline in severe alcoholic hepatitis: a prospective, randomised trial.","volume":"60","author":"Sidhu","year":"2012","unstructured":"Sidhu SS, Goyal O, Singla M, Bhatia KL, Chhina RS, Sood A. Pentoxifylline in severe alcoholic hepatitis: a prospective, randomised trial. J Assoc Physicians India. 2012 May;60:20-2. | PubMed |","journal-title":"J Assoc Physicians India","ISSN":"http:\/\/id.crossref.org\/issn\/0004-5772","issn-type":"print"},{"issue":"1","key":"ref6","first-page":"307","article-title":"Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial. JAMA. 2013 Sep 11;310(10):1033-41. | CrossRef | PubMed | European Association for the Study of Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol. 2012 Aug;57(2):399-420. | CrossRef | PubMed | O'Shea RS, Dasarathy S, McCullough AJ; Practice Guideline Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease.","volume":"51","author":"Thursz","year":"2010","unstructured":"Thursz MR, Richardson P, Allison M, Austin A, Bowers M, Day CP, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015 Apr 23;372(17):1619-28. | CrossRef | PubMed | Mathurin P, Louvet A, Duhamel A, Nahon P, Carbonell N, Boursier J, et al. Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial. JAMA. 2013 Sep 11;310(10):1033-41. | CrossRef | PubMed | European Association for the Study of Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol. 2012 Aug;57(2):399-420. | CrossRef | PubMed | O'Shea RS, Dasarathy S, McCullough AJ; Practice Guideline Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease. Hepatology. 2010 Jan;51(1):307-28. | CrossRef | PubMed |","journal-title":"Hepatology","ISSN":"http:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"}],"container-title":["Medwave"],"original-title":["\u00bfEs efectiva la pentoxifilina en hepatitis alcoh\u00f3lica? - Primera actualizaci\u00f3n"],"link":[{"URL":"https:\/\/www.medwave.cl\/link.cgi\/Medwave\/PuestaDia\/ResEpis\/6469","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T22:07:57Z","timestamp":1568066877000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medwave.cl\/link.cgi\/Medwave\/PuestaDia\/ResEpis\/6469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,14]]},"references-count":7,"journal-issue":{"issue":"Suppl2","published-online":{"date-parts":[[2016,6,14]]}},"URL":"https:\/\/doi.org\/10.5867\/medwave.2016.6469","relation":{},"ISSN":["0717-6384"],"issn-type":[{"value":"0717-6384","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,14]]}}}